StanleyNealCohenMD

PubMed

• 4 citations
  The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids.
  Kenneth G. Saag, Michele McDermott, Jonathan D. Adachi, Willem F. Lems, Nancy E Lane, Piet Geusens, Robert Kees Stad, Li Chen, Shuang Huang, Robin K. Dore, Stanley N. ...> ;Arthritis & Rheumatology. 2021 Sep 17
• 13 citations
  A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
  Stanley N. Cohen, Alvin F. Wells, Jeffrey R. Curtis, Rajat Dhar, Theodore Mellors, Lixia Zhang, Johanna B. Withers, Alex Jones, Susan Dina Ghiassian, Mengran Wang, Eri...> ;Rheumatology and Therapy. 2021 Jun 19
• 24 citations
  Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
  Philip G. Conaghan, Eduardo Mysler, Yoshiya Tanaka, Barbara Da Silva-Tillmann, T. Shaw, J. Liu, Ryan Ferguson, Jeffrey Enejosa, Stanley N. Cohen, Peter Nash, William F...> ;Drug Safety. 2021 Feb 2
• 88 citations
  American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
  Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, W. Winn Chatham, Stanley N. Cohen, Karen H. Costenbader, E...> ;Arthritis & Rheumatology. 2021 Feb 1
• 8 citations
  Substrate-dependent effects of quaternary structure on RNase E activity.
  Christopher J. Moore, Ha-Young Go, Eunkyoung Shin, Hye-Jeong Ha, Saemee Song, Nam-Chul Ha, Yong-Hak Kim, Stanley N. Cohen, Kangseok Lee> ;Genes & Development. 2021 Feb 1
• 10 citations
  A Randomized, Double-Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moder...
  Gerd R Burmester, David Chien, Vincent Chow, Melissa A. Gessner, Jean Pan, Stanley N. Cohen> ;Clinical Pharmacology in Drug Development. 2020 Nov 1
• 4 citations
  Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-se...
  Gerd Burmester, Edit Drescher, Pawel Hrycaj, David Chien, Zhiying Pan, Stanley Cohen> ;Clinical Rheumatology. 2020 Nov 1
• Correction to: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with...
  Gerd Burmester, Edit Drescher, Pawel Hrycaj, David Chien, Zhiying Pan, Stanley Cohen> ;Clinical Rheumatology. 2020 Nov 1
• 15 citations
  Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
  Eli Zuckerman, Julio A. Gutierrez, Douglas E. Dylla, Victor de Ledinghen, Andrew J. Muir, Michael Gschwantler, Massimo Puoti, Florin Caruntu, Jihad Slim, Frederik Neve...> ;Clinical Gastroenterology and Hepatology. 2020 Oct 1
• 123 citations
  Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and f...
  Philip J. Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel M. Kremer, Jeff Greenberg, Wendi Malley, Alina Onofrei, Keith...> ;Annals of the Rheumatic Diseases. 2020 Aug 5
• 140 citations
  American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
  Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, W. Winn Chatham, Stanley Cohen, Karen H. Costenbader, Elle...> ;Arthritis & Rheumatology. 2020 Aug 1
• 56 citations
  American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.
  Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, W. Winn Chatham, Stanley Cohen, Karen H. Costenbader, Elle...> ;Arthritis & Rheumatology. 2020 Sep 1
• 70 citations
  Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study).
  Stanley N. Cohen, Katie Tuckwell, Tamiko R. Katsumoto, Rui Zhao, Joshua Galanter, Chin Lee, Julie Rae, Balazs Toth, Nandhini Ramamoorthi, Jason A. Hackney, Alberto Ber...> ;Arthritis & Rheumatology. 2020 Apr 9
• 13 citations
  Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis
  Mark C. Genovese, Juan Sánchez-Bursón, MyungShin Oh, Éva Balázs, Jeffrey Neal, Andrea Everding, Tomas Hala, Rafal Wojciechowski, Gary Fanjiang, Stanley Cohen> ;Arthritis Research & Therapy. 2020 Mar 26
• 190 citations
  Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled...
  Josef S Smolen, Aileen L. Pangan, Paul Emery, William F. C. Rigby, Yoshiya Tanaka, Juan Ignacio Vargas, Y. Zhang, Nemanja Damjanov, Alan Friedman, Ahmed A. Othman, Hei...> ;Lancet. 2019 Jun 8
• 56 citations
  Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phas...
  Désirée van der Heijde, Vibeke Strand, Yoshiya Tanaka, Edward C. Keystone, Joel M. Kremer, Cristiano A. F. Zerbini, Mario H. Cardiel, Stanley Cohen, Peter Nash, Yeong ...> ;Arthritis & Rheumatology. 2019 Jun 1
• 28 citations
  An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
  Stanley Cohen, José L. Pablos, Karel Pavelka, Gerard Anton Müller, Alan Matsumoto, Alan Kivitz, Hui Wang, Eswar Krishnan> ;Arthritis Research & Therapy. 2019 Mar 29
• 17 citations
  Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from ...
  Rieke Alten, Bogdan Batko, Tomas Hala, Hideto Kameda, Sebastião Cezar Radominski, Vira Tseluyko, Goran Babic, Carol Cronenberger, Sarah Hackley, Muhammad I. Rehman, Ol...> ;RMD Open. 2019 Mar 1
• 17 citations
  Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established...
  Yael Haberman, Melanie Schirmer, Phillip Dexheimer, Rebekah Karns, Tzipi Braun, Mi-Ok Kim, Thomas D. Walters, Robert N. Baldassano, Joshua D. Noe, Joel R. Rosh, James ...> ;Mucosal Immunology. 2019 Mar 1
• 29 citations
  A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase...
  Alan Kivitz, Stanley Cohen, Edward C. Keystone, Ronald F van Vollenhoven, Boulos Haraoui, Jeffrey L. Kaine, Haiyun Fan, Carol A. Connell, Eustratios Bananis, Liza Taki...> ;Seminars in Arthritis and Rheumatism. 2018 Jul 19
• 2 citations
  Correction: Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R.
  Kangyun Wu, Jovanka Koo, Xiuju Jiang, Ran Chen, Stanley N. Cohen, Carl Nathan> ;Plos One. 2018 Oct 5
• 23 citations
  The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.
  Heyman, M. B., Livia Lindoso, Kajari Mondal, Suresh Venkateswaran, Hari K. Somineni, Cortney R. Ballengee, Thomas D. Walters, Anne M. Griffiths, Joshua D. Noe, Wallace...> ;The American Journal of Gastroenterology. 2018 Oct 1
• 1 citations
  Farewell Stan Stanley Falkow: 1934-2018.
  Felipe C. Cabello, Stanley N. Cohen, Roy Curtiss, Gordon Dougan, J. van Embden, B. B. Finlay, Fred Heffron, Donald R. Helinski, R. Hull, S. Hull, Ralph R. Isberg, D. J...> ;Environmental Microbiology. 2018 Jul 1
• 55 citations
  Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.
  Stanley N. Cohen, Jeffrey R. Curtis, Ryan DeMasi, Yan Chen, Haiyun Fan, Arif Soonasra, Roy Fleischmann> ;Rheumatology and Therapy. 2018 Feb 22
• 126 citations
  Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III ...
  Stanley Cohen, Mark C. Genovese, Ernest Choy, Fernando Perez-Ruiz, Alan Matsumoto, Karel Pavelka, José L. Pablos, Warren Rizzo, Paweł Hrycaj, N Zhang, William Shergy, ...> ;Annals of the Rheumatic Diseases. 2017 Oct 1
• Join now to see all

Journal Articles

• Stroke risk factor profiles in African American women.  
  Worrall BB, Johnston KC, Kongable G, Hung E, Richardson D, Gorelick PB, AAASPS Investigators, Stroke; 33:913-919
• Symptoms spread to contiguous body parts as a presentation of cerebral ischemia.  
  Cohen SN, Muthukumaran A, El-Saden S, Hathout G, Cerebrovasc Dis; 14(2):84-9
• Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis.  
  Streifler JY, Eleasziw M, Benevente OR, Alamowitch S, Fox AJ, Hachinski VC, Barnett HJM, NASCET Investigators, Stroke; 33:1651-1655
• Identifying pateints with symptomatic carotid artery disease at high risk of severe myocardial infarction and cardiac death.  
  Gates PC, Eliasziw M, Algra A, Barnett HJM, Gunton RW, NASCET Trial Group, Stroke; 33:2413-2416
• Awareness, treatment, and control of vascular risk factors in African Americans with stroke.  
  Ruland S, Raman R, Chaturvedi S, Leurgans S, Gorelick PB, AAASPS Investigators, Neurology; 60:64-68
• Design, Progress and Challenges of a Double Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis.  
  Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators, Neuroepidemiology; 22:106-17
• Risk, types and severity of Intracranial hemorrhage in patients with symptomatic carotid artery stenosis.  
  Cheung R, Eliasziw M, Meldrum HE, Fox AJ, Barnett HJM, NASCET Group, Stroke; 34:1847-51
• Development and progression of leukoariosis in patients with brain ischemia and carotid artery disease.  
  Streifler JY, Eliasziw M, Benevente OR, Alamowitch S, Fox AJ, Hachinski V, Barnett HJM, NASCET Group, Stroke; 34:1913-17
• Side of brain infarction and long-term risk of sudden death in patients with symptomatic carotid disease.  
  Algra A, Gates PC, Fox AJ, Hachinski V, Barnett HJM, NASCET Group, Stroke; 34:2871-75
• Lowering homocysteine in patients with ischemic stroke to prevent stroke, myocardial infarction and death.  
  Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang, CH, Staamfer M, JAMA; 291:565-75
• Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA): Design of a Prospective, Multi-center Trial of Diagnostic Tests.  
  The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial Investigators, Neuroepidemiology; 23:23-32
• Risk and benefit of endarterectomy in women with symptomatic internal carotid artery disease.  
  Alamowitch S, Eliasziw M, Barnett HJM, NASCET and ASA and Carotid Endarterectomy Trial Groups, Stroke; 36:27-31
• Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis.  
  Chimowitz MI., Lynn MJ, Howlett-Smith H, Stern BJ., Hertzberg VS, Franke MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, Warfarin–As..., N Engl J Med; 352:1305-1316
• Carotid Endarterectomy. Report of the Therapeutics and Technology Assessment Subcommittee.  
  Chaturvedi S, Bruno A, Feasby T, Holloway R, Benevente O, Cohen SN, Cote R, Hess D, Saver J, Spence D, Stern B, Wilterdink J, AAN Therapeutics and Technology Subcommittee, Neurology; 65:794-801
• Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.  
  Kasner SE, Chimowitz MI, Lynn MJ, Howell-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Clott HJ, WASI..., Circulation; 113:555-563
• Impact of metabolic syndrome on prognosis of symptomatic intracranial atherosclerosis.  
  Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M, WASID Investigators, Neurology; 66:1344-1349
• Carotid endarterectomy in patients with tandem lesions.  
  Cohen SN, Surgery; 94:525
• Comparison of critical frequency of photic driving and pattern reversal evoked potentials.  
  Cohen SN, Syndulko K, Tourtellotte WW, Arch Neurol; 43:313
• Asymptomatic carotid stenosis.  
  Toole JF, Asymptomatic Carotid Stenosis Study Group, N Engl J Med; 316:1087-1088
• Occipital infarction with hemianopsia from carotid occlusive disease.  
  Cohen SN, Stroke; 20:1433-1434
• Self-referral by physicians.  
  Cohen SN, N Engl J Med; 328:1276
• Dipyridamole plus aspirin in cerebrovascular disease.  
  Cohen SN, Arch Neurol; 57:1086-1087
• Critical frequency of photic driving in the diagnosis of multiple sclerosis: A comparison to pattern evoked responses.  
  Cohen SN, Syndulko K, Tourtellotte WW, Potvin AR, Arch Neurology; 37:80-83
• Stroke in patients with asymptomatic internal-carotid-artery stenosis.  
  Cohen SN, Toole JF, N Eng J Med; 343:1420-1421
• The extracranial-intracranial bypass: Neurologic aspects.  
  Cohen SN, Bull LA Neurologic Soc; 45:33-39
• Join now to see all

Books/Book Chapters

• Brain Attack! 
  Chapter: Carotid endarterectomy for asymptomatic stenosis 
  Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• Brain Attack! 
  Chapter: Preventing stroke in atrial fibrillation 
  Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• Brain Attack! 
  Chapter: Stroke prevention in atrial fibrillation 
  Page 103 - 112Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• Outpatient Care Handbook. 
  Chapter: Carotid Stenosis 
  Page 101 - 104Cohen SNEditors: Glassman PA, Garcia D, Delafield JP.Hanley & Belfus, Philadelphia
• Brain Attack! 
  Chapter: Antiplatelet armamentarium: choosing an agent 
  Page 81 - 94Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• Management of Acute Ischemic Stroke. 
  Chapter: Diagnosis and management of dissection 
  Page 277 - 290Salari H, Cohen SNEditors: Cohen SN.McGraw-Hill, New York
• Management of Acute Ischemic Stroke. 
  Chapter: Subacute management of stroke - Secondary stroke prevention 
  Page 89 - 110Cohen SNEditors: Cohen SN.McGraw-Hill, New York
• Brain Attack 2000! 
  Chapter: Atrial fibrillation:An undertreated epidemic 
  Page 59 - 73Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• Brain Attack 2001! 
  Chapter: Preventing stroke in atrial fibrillation: Update 2001 
  Page 123 - 142Cohen SNEditors: Martin N, Vinuela F, Dobkin B, Saver J, Starkman S.Los Angeles
• The prevention of stroke. 
  Chapter: Antiplatelet and anticoagulant therapies for prevention of first and recurrent stroke 
  Page 193 - 207Cohen SN, Schneck MEditors: Gorelick P, Alter M.Parthenon Publishing, Boca Raton
• Practical Pulmonary and Critical Care. 
  Chapter: Neurological emergencies in the intensive care unit 
  Selco S, Somerto A, Cohen SNEditors: Mosenifar Z, SooHoo G.Marcel Dekker
• Scientific Basis, Methods, Analysis and Modeling (Selected Reprints). VA Technical Book. 
  Chapter: Evoked Responses in Multiple Sclerosis and the Effects of Core Temperature 
  Phillips KR, Syndulko K, Cohen SN, Potvin AR, Tourtellotte WW, Potvin JHVA Wadsworth Medical Center Press, Los Angeles, CA
• Neurology 1991: An Update Course. 
  Cohen SNPrivate Publishing, Los Angeles, CA
• International Conference on Clinical Issues in Epilepsy. 
  Cohen SNPrivate Publishing, Los Angeles, CA
• Management of Acute Ischemic Stroke. 
  Cohen SNMcGraw-Hill, New York
• Evoked Responses in Multiple Sclerosis and the Effects of Core Temperature: Scientific Basis, Methods, Analysis and Modeling (Selected Reprints). VA Technical Book. 
  Chapter: Evoked responses: The wave of the future? 
  Page 167 - 187Cohen SNEditors: Phillips KR, Syndulko K, Cohen SN, Potvin AR, Tourtellotte WW, Potvin JH.VA Wadsworth Medical Center Press, Los Angeles, CA
• The Aging Nervous System. 
  Chapter: Electrophysiological measurement in aging and dementia 
  Page 187 - 210Hansch EC, Syndulko K, Pirozzolo FJ, Cohen SN, Tourtellotte WW, Potvin AREditors: Maletta GJ and Pirozzolo FJ.Praeger, New York
• Clinical Applications of Evoked Potentials in Neurology. 
  Chapter: Variability on serial testing of visual evoked potentials in patients with multiple sclerosis 
  Page 559 - 566Cohen SN, Syndulko K, Hansch EC, Tourtellotte WW, Potvin AREditors: Courjon J, Maugiere F, Revol M.Raven Press, New York
• Clinical Applications of Evoked Potentials in Neurology. 
  Chapter: Long latency event related potentials in normal aging and dementia 
  Page 279 - 286Syndulko K, Hansch EC, Cohen SN, Pearce JW, Goldberg ZI, Montan B, Tourtellotte WW, Potvin AREditors: Courjon J, Maugiere F, Revol M.Raven Press, New York
• Clinical Applications of Evoked Potentials in Neurology. 
  Chapter: Improved diagnostic yield in the evaluation of multiple sclerosis using pattern reversal evoked potentials 
  Page 459 - 462Cohen SN, Syndulko K, Hansch EC, Gilden E, Phillips K, Tourtellotte WW, Potvin AREditors: Courjon J, Maugiere F, Revol M.Raven Press, New York
• Diagnosis of Multiple Sclerosis. 
  Chapter: Visual evoked potentials in the diagnosis of multiple sclerosis 
  Page 103 - 119Cohen SN, Syndulko K, Tourtellotte WWEditors: Poser C.Thieme-Stratton, New York
• Evoked Potentials II. 
  Chapter: P300 and neurocognitive function in neurologic patients 
  Page 441 - 445Syndulko K, Cohen SN, Pettler-Jennings P, Shah J, Friedman A, Potvin AR, Tourtellotte WWEditors: Nodar RH and Barber C.Butterworth, Boston
• Surgery for Cerebrovascular Disease. 
  Chapter: Intellectual function following carotid endarterectomy 
  Page 667 - 678Cohen SNEditors: Moore WS.Churchill Livingston, New York
• Intensive Course in Geriatric Medicine Syllabus. 
  Chapter: Treatment of stroke and TIA in the elderly 
  Page 237 - 244Cohen SNEditors: Soloman D.
• Neurology Board Review Course Sylabus. 
  Chapter: Cerebrovascular diseases: Review course 
  Cohen SNEditors: Riley T.
• Join now to see all

Abstracts/Posters

• African American Antiplatelet Stroke Prevention Study (AAASPS).
  Gorelick PB, Leurgans S, Newkirk C, AAASPS Investigators, Stroke; 30:257
• Extent of the diagnostic work up in African American stroke patients.
  Schneck MJ, Leurgans S, Raman R, Gorelick PB, AAASPS Investigators, Neurology; 52:A557
• Treatment of cardiovascular risk factors in African American stroke patients.
  Schneck MJ, Leurgans S, Raman R, Gorelick PB, AAASPS Investigators, Stroke; 30:253
• Physician preferences for the diagnosis and treatment of symptomatic intracranial arterial stenosis.
  Chimowitz MI, Williams J, Stern BJ, Cotsonis G, Swanson S, Lynn M, Feldman E, WASID Investigators, Stroke Section of AAN, Neurology; 62:A266-267
• The importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery.
  Kappelle LJ, Eliaziw M, Fox AJ, Sharpe BL, Barnett HJM, NASCET Investigators, Stroke; 30:240
• Is the evolution of internal carotid artery stenosis associated with ipsilateral ischemic stroke in medically treated patients with 70-99% stenosis?
  Paciaroni M, Sharpe BL, Eliasziw M, Kappelle J, Barnett HJM, NASCET Investigators, Stroke; 30:256
• Prognostic importance of leukoariosis in patients with ischemic events and carotid artery disease.
  Streifler JY, Eliasziw M, Fox AJ, Barnet HJM, NASCET Investigators, Stroke; 30:254
• Assessing cerebral perfusion in a patient with moyamoya using CT Perfusion (CTP) and SPECT.
  Cohen SN, Moser FG, Waxman A, Maya M, D’Agnolio A, Tourje EJ, Young SM, Pressman BD, Schievink WI, Stroke; 35:e171
• Screening of plasma homocyst(e)ine levels in stroke patients for the Vitamin Intervention for Stroke Prevention clinical trial.
  Malinow MR, Chambless LE, Howard VJ, Toole JF, VISP Investigators, Stroke; 30:258
• Silent Infarcts in First-Ever Stroke.
  Abedi G, Singh R, Wong J, Kaur J, Birmingham N, Cohen SN, Neurology; 52
• The incidence or discontinuation of anti-platelet therapy and warfarin within stroke subtypes.
  Dergalust S, Cheng EM, Panizzon KL, El-Saden S, Tsuprun J, Rubiova Z, Cohen SN, Wallis RA, Stroke; 35:e61
• Intra- and Extra-Cranial Stenosis and Risk Factor Analysis in Stroke Patients: Racial Differences.
  Singh R, Abedi G, Kaur J, Wong J, Ryan P, Birmingham N, Cohen SN, Neurology; 52
• Target blood pressure and risk of recurrent stroke in patients with intracranial arterial stenosis.
  Turan TN, Lynn M, Cotsonis G, Chaturvedi S, Chimowitz M, the WASID Trial Investigators, Stroke; 36:456-457
• Warfarin vs. aspirin for symptomatic intracranial stenosis: subgroup analysis from WASID.
  Lynn M, Chimowitz M, Howlett-Smith H, et al. WASID Study Group, Stroke; 36:457
• The metabolic syndrome is highly prevalent and increases the risk of recurrent vascular events amongst individuals withsymptomatic intracranial atherosclerotic disease.
  Ovbiagele B, Saver JL, Cotsonis G, Lynn M, Chimowitz M, the WASID Study Group, Neurology; 64: A150
• Influence of risk factors on subsequent vascular events in patients with symptomatic intracranial stenosis.
  Chaturvedi S, Lynn M, Frankel M, et al., WASID Study Group, Neurology; 64: A420
• Predictors of ischemic stroke in the territory of a symptomatic intracranial stenosis.
  Chimowitz M, Kasner S, Lynn M, et al for the WASID investigators, Cerebrovasc Dis; 19 (suppl2): 69
• Is left ventricular hypertrophy a predictor of vascular event rate in African American stroke patients?
  Chaturvedi S, Hung E, Choi J, Cohen SN, Nassief A, Richardson D, Leurgans S, Gorelick P, International Stroke Conference 2005, New Orleans
• Statin use and ischemic stroke rate in patients with symptomatic intracranial stenosis.
  Chaturvedi S, Lynn M, Bruno A, Mohammed Y, Wityk R, Chimowitz MI, WASID Study Group, International Stroke Conference
• Causes and Severity of Stroke in Patients with Symptomatic Intracranial Stenosis.
  Famakin BM, Lynn MJ, George MG, Chimowitz MI, WASID Investigators, International Stroke Conference, Kissimmiee, Florida
• Echocardiographic Findings In Patients With Symptomatic Intracranial Stenosis.
  Kasner SE, Lynn MJ, Jackson BP, Pullicino PM, Chimowitz MI, WASID Trial Investigators, International Stroke Conference Kissimmiee, Florida
• Racial Differences in Risk Factor Management in the Warfarin vs. Aspirin for Symptomatic Intracranial Disease Trial.
  Waddy S, Cotsonis G, Lynn M, Frankel M, Chaturvedi S, Chimowitz MI, WASID investigators, International Stroke Conference, Kissimmiee, Florida
• Intracranial Stenosis, “Failure” Of Antithrombotic Therapy, And Risk Of Stroke.
  Maidan L, Lynn M, Cotsonis G, Upchurch T, Levine S, Romano J, Chimowitz MI, WASID investigators, International Stroke Conference, Kissimmiee, Florida
• Risk Factors for Severe Intracranial Arterial Stenosis.
  Makki AA, Turan TN, Cotsonis GA, Lynn MJ, Chimowitz MI, WASID Trial Investigators, International Stroke Conference, Kissimmiee, Florida
• Characterization of the Hemorrhage Subjects in the Warfarin vs Aspirin Symptomatic Intracranial Disease (WASID) trial.
  Johnston KC, Lynn MJ, Gaines KJ, Smith KJ, Chimowitz MI, WASID investigators, International Stroke Conference, Kissimmiee, Florida
• Join now to see all

Lectures

• International Conference on Clinical Issues in Epilepsy. 
  VA WLA, Los Angeles Symposium
• Stroke in Women, Minorities, and Children. 
  American Heart Association 61st Fall Symposium, Los Angeles
• Overview of Stroke. 
  Medicine rounds, High Desert Hospital, Lancaster, CA
• Thrombotic Stroke: Etiology, Diagnosis, and Treatment. 
  Family Physicians Meeting, Kaiser San Gabriel Valley, CA
• Advances in the Diagnosis and Treatment of Stroke. 
  Edward Stern Neuroscience Symposium, El Paso, Texas
• Update on Prevention of Stroke. 
  American Healthcare Conference “From Clinical Trials to Real World,” Las Vegas, NV
• Treating Stroke. 
  American Heart Association, Los Angeles
• Intensive Course in Geriatric Medicine. 
  American Geriatrics Society, Los Angeles
• Imaging in Stroke, an Update. 
  Radiology Rounds, VA West LA
• Stroke. 
  American Geriatrics Society Intensive Course in Geriatric Medicine, Los Angeles
• Update From Stroke Meetings. 
  Neurology Grand Rounds, VA West Los Angeles
• Update in Stroke Prevention and Therapies. 
  Medicine Conference, Little Company of Mary Hospital, Torrance
• Stopping Antithrombotics PreOp. 
  G.U Grand Rounds, VA West Los Angeles
• Fundamentals of Stroke. 
  Diabetic Support Group, VA Outpatient Clinic, Santa Barbara
• Carotid Artery Stenosis. 
  Medicine Rounds, Anaheim General Hospital, Anaheim, CA
• Malpractice in Neurology. 
  Grand Rounds, VA West LA
• Using the Results of the Asymptomatic Carotid Atherosclerosis Study. 
  Argentine Congress of Cardiology - Buenos Aires
• Treatment Options in the Prevention of Secondary Stroke. 
  City of Hope Rational Therapeutics: A Seminar in General Medicine, Anaheim, CA
• Atrial Fibrillation – An Undertreated Epidemic. 
  Brain Attack! 2001, UCLA, Beverly Hills, CA
• Surgical Intervention for Carotid Atherosclerotic Disease. 
  Multiple locations, 1995
• Carotid Endarterectomy in Asymptomatic Carotid Stenosis. 
  Brain Attack! ’95, UCLA, Santa Monica, CA
• Update on Management of Ischemic Stroke. 
  Medical conference, Alhambra Hospital, LA, CA
• Prevention of Stroke. 
  Medicine Grand Rounds, Overvue Medical Center, Bellvue, WA
• Stroke Prevention in Atrial Fibrillation. 
  Multiple locations, 1996
• Management of Carotid Stenosis in Patients with CAD. 
  Cardiology Grand Rounds, VAWLA, Los Angeles
• Join now to see all

Other

• Stroke Prevention. 
  Cohen SN, National Stroke Association Stroke Conversation Series Web Broadcast